GPR55 regulates the responsiveness to, but does not dimerise with, α 1A -adrenoceptors

Emerging evidence suggests that G protein coupled receptor 55 (GPR55) may influence adrenoceptor function/activity in the cardiovascular system. Whether this reflects direct interaction (dimerization) between receptors or signalling crosstalk has not been investigated. This study explored the intera...

Full description

Saved in:
Bibliographic Details
Published inBiochemical pharmacology Vol. 188; p. 114560
Main Authors Walsh, Sarah K, Lipina, Christopher, Ang, Sheng Y, Sato, Masaaki, Chia, Ling Yeong, Kocan, Martina, Hutchinson, Dana S, Summers, Roger J, Wainwright, Cherry L
Format Journal Article
LanguageEnglish
Published England 01.05.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Emerging evidence suggests that G protein coupled receptor 55 (GPR55) may influence adrenoceptor function/activity in the cardiovascular system. Whether this reflects direct interaction (dimerization) between receptors or signalling crosstalk has not been investigated. This study explored the interaction between GPR55 and the alpha 1A-adrenoceptor (α -AR) in the cardiovascular system and the potential to influence function/signalling activities. GPR55 and α -AR mediated changes in both cardiac and vascular function was assessed in male wild-type (WT) and GPR55 homozygous knockout (GPR55 ) mice by pressure volume loop analysis and isolated vessel myography, respectively. Dimerization of GPR55 with the α -AR was examined in transfected Chinese hamster ovary-K1 (CHO-K1) cells via Bioluminescence Resonance Energy Transfer (BRET). GPR55 and α -AR mediated signalling (extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation) was investigated in neonatal rat ventricular cardiomyocytes using AlphaScreen proximity assays. GPR55 mice exhibited both enhanced pressor and inotropic responses to A61603 (α -AR agonist), while in isolated vessels, A61603 induced vasoconstriction was attenuated by a GPR55-dependent mechanism. Conversely, GPR55-mediated vasorelaxation was not altered by pharmacological blockade of α -ARs with tamsulosin. While cellular studies demonstrated that GPR55 and α -AR failed to dimerize, pharmacological blockade of GPR55 altered α -AR mediated signalling and reduced ERK1/2 phosphorylation. Taken together, this study provides evidence that GPR55 and α -AR do not dimerize to form heteromers, but do interact at the signalling level to modulate the function of α -AR in the cardiovascular system.
ISSN:1873-2968